Asset Management One’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-13,314
| Closed | -$551K | – | 1033 |
|
2022
Q3 | $551K | Hold |
13,314
| – | – | ﹤0.01% | 877 |
|
2022
Q2 | $794K | Hold |
13,314
| – | – | ﹤0.01% | 859 |
|
2022
Q1 | $966K | Hold |
13,314
| – | – | ﹤0.01% | 857 |
|
2021
Q4 | $1.1M | Hold |
13,314
| – | – | ﹤0.01% | 860 |
|
2021
Q3 | $1.2M | Hold |
13,314
| – | – | ﹤0.01% | 842 |
|
2021
Q2 | $1.27M | Hold |
13,314
| – | – | ﹤0.01% | 844 |
|
2021
Q1 | $1.52M | Hold |
13,314
| – | – | 0.01% | 823 |
|
2020
Q4 | $1.96M | Hold |
13,314
| – | – | 0.01% | 786 |
|
2020
Q3 | $1.09M | Sell |
13,314
-4,873
| -27% | -$400K | 0.01% | 828 |
|
2020
Q2 | $1.42M | Hold |
18,187
| – | – | 0.01% | 800 |
|
2020
Q1 | $808K | Hold |
18,187
| – | – | ﹤0.01% | 834 |
|
2019
Q4 | $777K | Hold |
18,187
| – | – | ﹤0.01% | 896 |
|
2019
Q3 | $778K | Hold |
18,187
| – | – | ﹤0.01% | 893 |
|
2019
Q2 | $1.16M | Sell |
18,187
-18,449
| -50% | -$1.17M | 0.01% | 871 |
|
2019
Q1 | $2.54M | Buy |
36,636
+5,706
| +18% | +$396K | 0.01% | 750 |
|
2018
Q4 | $1.3M | Sell |
30,930
-421
| -1% | -$17.7K | ﹤0.01% | 837 |
|
2018
Q3 | $2.5M | Sell |
31,351
-6,982
| -18% | -$557K | 0.01% | 796 |
|
2018
Q2 | $2.92M | Sell |
38,333
-10,206
| -21% | -$777K | 0.01% | 800 |
|
2018
Q1 | $2.48M | Hold |
48,539
| – | – | 0.01% | 801 |
|
2017
Q4 | $2.28M | Hold |
48,539
| – | – | 0.01% | 832 |
|
2017
Q3 | $2.62M | Hold |
48,539
| – | – | 0.01% | 814 |
|
2017
Q2 | $3M | Buy |
48,539
+7,320
| +18% | +$453K | 0.01% | 760 |
|
2017
Q1 | $2.77M | Buy |
41,219
+17,600
| +75% | +$1.18M | 0.01% | 760 |
|
2016
Q4 | $1.66M | Buy |
23,619
+2,602
| +12% | +$183K | ﹤0.01% | 784 |
|
2016
Q3 | $1.44M | Buy |
21,017
+17,435
| +487% | +$1.2M | 0.02% | 722 |
|
2016
Q2 | $177K | Buy |
+3,582
| New | +$177K | ﹤0.01% | 1213 |
|